Mycoplasma bovis is an emerging bacterial agent causing bovine mastitis. Although these cell wall-26 free bacteria lack classical virulence factors, they are able to activate the immune system of the 27 host. However, effects on the bovine mammary immune system are not yet well characterized and 28 
Introduction 45
Mycoplasmas represent the smallest self-replicating microorganisms characterized by a minimal 46 genome, and by the lack of a cell wall (Razin et al., 1998) . In dairy cattle, Mycoplasma bovis 47 belongs to the most prevalent contagious mastitis pathogens (Olde Riekerink et al., 2006) that is 48 often unresponsive to antibiotics and tends to cause chronic infections (Kauf et al., 2007) . 49
In general, bacterial species and strain specific severities of mastitis are characterized by differences 50 in their induction of the mammary immune system, i.e. the regulation of several immune factors 51 (i.e. cytokines) and recognition receptors (i.e. toll-like receptors; TLR) (Wellnitz and Bruckmaier, 52 2012; Zbinden et al., 2014) . M. bovis displays a broad range of immunogenic and 53 immunosuppressive characteristics that determine its pathogenicity. The extensive variation of cell 54 surface antigens, also known as variable surface proteins (Vsps), enables the pathogen to evade the 55 host immunity which contributes to the persistent nature of M. bovis infections (Razin et al., 1998; 56 Buchenau et al., 2010) . Among these Vsps, lipoproteins represent the most abundant fraction (Razin 57 et al., 1998) . Besides their antigenic properties, lipoproteins play a central role in adhesion and are 58 expected to trigger the production of pro-inflammatory cytokines (Pilo et al., 2007) . Furthermore, 59
Mycoplasma-derived secondary metabolites have been demonstrated to exert cytotoxic effects in 60 infected host cells (Pilo et al., 2005) . 61
As M. bovis resists antibiotic therapies, it is of high importance to understand the bovine 62 mammary immune response to this pathogen to optimize prevention and therapy strategies of 63 mycoplasmal mastitis in dairy cows. Therefore, the objective of the present study was to investigate 64 the innate immune response of bovine mammary epithelial cells (bMEC) to M. bovis, characterized 65 by the mRNA expression of selected immune factors. Primary cultures of bMEC challenged with 66 live and heat-inactivated M. bovis were used to investigate host-pathogen interactions that trigger 67 the immune reaction in the mammary epithelium. 68
Materials and Methods 70

M. bovis strains 71
The field strain JF4278, isolated from mastitic milk in 2008 in Switzerland (Aebi et al., 2012) , and 72 the type strain PG45 (Hale et al., 1962) were used in this study. M. bovis cultures were grown in 73 SP4 broth medium supplemented with 50 μg/ml cefoxitin sodium salt (Sigma-Aldrich, Buchs, 74 Switzerland) for 18 hours (Freundt, 1983) . 75
To standardize the assays, standard growth curves relating turbidity (OD 600 ) of liquid cultures to 76 colony forming units (CFU) of M. bovis were obtained by determining colony counts on SP4 agar 77 supplemented with 50 μg/ml cefoxitin sodium salt incubated for 3-4 days at 37 °C in a humidified 78 atmosphere. Growth of M. bovis was tested to assess variations among each individual SP4 batch. 79
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